Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.120
-0.010 (-0.24%)
Jun 30, 2026, 2:10 PM EDT - Market open
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $46.59 million as of June 30, 2026. Its market cap has increased by 15.93% in one year.
Market Cap
46.59M
Enterprise Value
21.43M
1-Year Change
15.93%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $46.59M, a decrease of -36.05%. That is a compound annual growth rate of -9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 46.59M | -21.18% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 49.59M |
| Lantern Pharma | 49.25M |
| Immutep | 48.84M |
| Eloxx Pharmaceuticals | 48.62M |
| Veru Inc. | 48.31M |
| Mereo BioPharma Group | 47.34M |
| CervoMed | 47.21M |
| Metagenomi Therapeutics | 47.06M |